Varex Imaging (VREX) EBITDA (2016 - 2026)

Varex Imaging (VREX) has 11 years of EBITDA data on file, last reported at $14.4 million in Q2 2026.

• On a quarterly basis, EBITDA fell 34.84% year-over-year to $14.4 million in Q2 2026; TTM through Apr 2026 was -$31.3 million, a 158.5% decrease from a year earlier, with the FY2025 full-year figure at -$27.8 million, down 186.6% from the prior year.
• EBITDA for Q2 2026 stood at $14.4 million, down from $15.4 million in the prior quarter.
• Over the last five years, EBITDA for VREX reached as high as $26.6 million in Q2 2022 and fell as low as -$80.7 million in Q3 2025.
• Historically, EBITDA has averaged $10.9 million across 5 years, with a median of $15.4 million in 2026.
• On a YoY basis, EBITDA climbed as much as 187.01% in 2025 and fell as far as 967.74% in 2025.
• Year by year, EBITDA stood at $13.0 million in 2022, then sank by 67.69% to $4.2 million in 2023, then jumped by 159.52% to $10.9 million in 2024, then jumped by 79.82% to $19.6 million in 2025, then slipped by 26.53% to $14.4 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $14.4 million in Q2 2026, $15.4 million in Q1 2026, and $19.6 million in Q4 2025.